IMMB — Immunotech Laboratories Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.06m
- $0.52m
Annual balance sheet for Immunotech Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2001 December 31st | 2002 December 31st | C2003 December 31st | 2004 December 31st | 2005 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10KSB | 10KSB | 10KSB/A | 10KSB/A | 10KSB |
| Standards: | — | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.067 | 0.009 | 0.005 | 0 | 0.047 |
| Total Current Assets | 0.067 | 0.009 | 0.005 | 0 | 0.047 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.105 | 0.002 | 0 | — | — |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.566 | 0.046 | 0.005 | 0 | 0.05 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.849 | 1.03 | 0.603 | 0.628 | 1.1 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.999 | 1.03 | 0.603 | 0.628 | 1.1 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.433 | -0.982 | -0.597 | -0.626 | -1.05 |
| Total Liabilities & Shareholders' Equity | 0.566 | 0.047 | 0.006 | 0.002 | 0.051 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |